Skip to main content
Log in

Effect of subdermal levonorgestrel contraceptive implants on vaginal candidiasis

  • Published:
Advances in Contraception

Abstract

A total of 150 women in 3 equal groups, each using a different contraceptive method (group I used Norplant, group II used the IUD and group III used combined OC pills) were investigated for the presence of vaginal candidiasis before and at various time intervals (3, 6 and 12 months) after starting to use the particular contraceptive method. The incidence of vaginalCandida albicans infection increased significantly among pill and IUD users, but with a much lower intensity among the latter cases. In Norplant users the increase was slight and insignificant. The explanation of these findings within the context of changes in local vaginal milieu is discussed.

Resumé

150 femmes, réparties en 3 groupes égaux utilisant chacun une méthode contraceptive différente (le groupe I utilisait Norplant®, le groupe II un DIU et le groupe III un contraceptif oral combiné), ont été observées afin de détecter la présence d'une candidose vaginale avant et à intervalles réguliers (3, 6 et 12 mois) après le début de l'emploi de l'une de ces méthodes contraceptives. L'infection vaginale à candida albicans a une incidence plus élevée mais une intensité moindre chez les utilisatrices de pilule et de DIU. Parmi les utilisatrices de Norplant, I'augmentation était légère et néglibeable. La discussion porte sur l'explication de ces résultats dans le contexte des modifications du milieu vaginal local.

Sumario

Un total de 150 mujeres en tres grupos iguales, cada uno usando un método anticonceptivo diferente (el grupo I usó Norplant, el grupo II usó DIU y el grupo III usó anticonceptivos orales combinados) fueron investigadas para la presencia de candidiasis vaginal, antes y luego de varios intervalos (3, 6 y 12 meses) después del comienzo del usó del método anticonceptivo aconsejado. La incidencia de infección vaginal por Candida albicans aumentó significativamente entre las usuarias de pastillas y de DIU pero, con mucho menos intensidad en las segundas. En usuarias de Norplant el aumento fue leve e insignificante. Se explican estos hallazgos en el contexto de cambios en el medio vaginal.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. SegalS. J. (1982). Contraceptive subdermal implants. InAdvances in Fertility Research, 2, D. R.Mishell, ed., Raven Press, New York, p. 117

    Google Scholar 

  2. JacksonJ. L. and SpainW. T. (1968). Comparative study of combined and sequential antiovulatory therapy on vaginal moniliasis.Am. J. Obstet. Gynecol.,101, 1134

    PubMed  Google Scholar 

  3. DiddleA. W., WilliamH., GardnerA., PerryJ. J., WilliamsonI., KennethA. and ConnerO. (1969). Oral contraceptive medication and vulvo vaginal candidiasis.Obstet. Gynecol.,34, 373

    PubMed  Google Scholar 

  4. Farris, E. (1975) A qualitative and quantitative study of the vaginal flora with special reference to monilia in relation to the use of oral contraceptives in Alexandria. PhD Thesis, University of Alexandria. Egypt, p. 96

  5. El-GhazzawiE., HamdyL., DarderyN. and SawyM. (1979). Effect of different contraceptives on microbial vaginal flora and immunoglobulin levels.J. Egypt. Publ. Health Assoc.,54, 39

    Google Scholar 

  6. CruickshankR., DuguidJ. P., MarnionB. P. and SwainR. H. A. (1975).Medical Microbiology: Microbial Infection, 12th edn., Churchill Livingstone, London, p. 264

    Google Scholar 

  7. HuisleyR., LeaskB. G. S. and FaktorJ. A. (1973). Incidence and distribution of yeast species and ofTrichomonas vaginalis in the vagina of pregnant women.J. Obstet. Gynaecol. Br. Commonw.,80, 252

    PubMed  Google Scholar 

  8. CatterallF. D. (1966).Candida albicans and the contraceptive pill.Lancet,2, 830

    PubMed  Google Scholar 

  9. SpellacyW. M. and CarlsowK. L. (1966). Plasma insulin and blood glucose levels in patients taking oral contraceptives.Am. J. Obstet. Gynecol.,95, 474

    PubMed  Google Scholar 

  10. PosnerN. A. (1967). Oral progestational agents as a cause of candida vaginitis.Obstet. Gynecol.,29, 79

    PubMed  Google Scholar 

  11. GoldacreM. J., WattB., LoudonN., MilneL. J. R., LoudonJ. D. O. and VesseyM. P. (1979). Vaginal microbial flora in normal young women.Br. Med. J.,1, 1450

    PubMed  Google Scholar 

  12. AugerP. and JolyT. (1980). Microbial flora associated withCandida albicans vulvovaginitis.Obstet. Gynecol.,55, 397

    PubMed  Google Scholar 

  13. CroxattoH. B., DiazS. and MirandaP. (1980). Plasma levels of levonorgestrel in women during long term use of Norplants.Contraception,22, 583

    PubMed  Google Scholar 

  14. ToppozadaM., OnsyF. A., FarrisE., AmerS. and ShaalaS. (1979). The protective influence of progestogen-only contraception against vaginal moniliasis.Contraception,20, 99

    PubMed  Google Scholar 

  15. Shoaib, A. (1983). Effect of the subcutaneous contraceptive implant ‘Norplant’ on the histological appearance of the endometrium. MS Thesis, Faculty of Medicine, University of Alexandria, Egypt, p. 84

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Toppozada, M., Amer, S. & El-Ghazzawi, E. Effect of subdermal levonorgestrel contraceptive implants on vaginal candidiasis. Adv Contracept 2, 117–122 (1986). https://doi.org/10.1007/BF01849220

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01849220

Keywords

Navigation